Immune Control Report issue

For profit Phase 2
Founded: Conshohocken PA United States (2001)
Status: Acquired by Corridor Pharmaceuticals (2010)

Organization Overview

First Clinical Trial
2006
NCT00335647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree